C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
申请人:Sutton C. James
公开号:US20060293336A1
公开(公告)日:2006-12-28
The present invention provides novel C-linked cyclic compounds and analogues of Formula (I):
or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, D and W are as defined herein. These compounds are selective inhibitors of the human P2Y
1
receptor which can be used as medicaments.
The replacement of fossil resources with biomass resources in the construction of N-heterocycles is rapidly attracting research interest. Herein, we report palladium-catalyzed selective hydrogenative coupling of nitroarenes and phenols based on a transfer hydrogenation strategy, allowing straightforward access to spirocyclic pyrrolo- and indolo-fused quinoxalines, a class of compounds found in numerous